Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular ...

Update: B-Cell and Follicular Lymphoma . Condition Center Home > Expert Q&A. Q&A: Sendhilnathan Ramalingam, MD, on Follicular Lymphoma Prognosis —Dr ...

Follicular lymphoma can develop into a faster-growing form known as diffuse large B-cell lymphoma. Transformed lymphoma is usually more aggressive and may require more rigorous treatment.

Ajay Gopal, MD: One characteristic regarding follicular lymphoma is, even though most will have a normal lifespan, it's a very difficult lymphoma to eradicate. ... CAR T-cell therapy KITE-363 showed ...

Under the microscope, we see that it's this cancer of white blood cells, typically a slow-growing cancer known as follicular lymphoma. The diagnosis is made by a hematopathologist, a specialized ...

But if your follicular lymphoma is resistant to treatment or comes back, your medical team may try epcoritamab-bysp (Epkinly) or mosunetuzumab (Lunsumio), which target two types of cells in your ...

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- ...

White blood cells are also known as B cells or B lymphocytes. These then collect in lymph nodes and elsewhere in the person’s body. Follicular lymphoma is usually incurable but responds well to ...

But if your follicular lymphoma is resistant to treatment or comes back, your team may consider mosunetuzumab (Lunsumio) as a combination CD20-antibody and CD3 T-cell treatment. Others include ...

Rituximab has changed the natural history of non-Hodgkin's lymphoma. The time to treatment failure and overall survival are improved with immunochemotherapy in diffuse large B-cell lymphoma (DLBCL). 1 ...

Follicular lymphoma (FL) is an indolent, B-cell lymphoproliferative disorder that accounts for about 20% of all cases of non-Hodgkin lymphoma (NHL). 1,2 Although findings from most studies point ...

This retrospective study demonstrated improved outcomes (progression-free survival and overall survival) in female patients with diffuse large B-cell lymphoma who received chemotherapy in the ...